Biotech · Public company · Carlsbad, CA, US

Lineage Cell Therapeutics, Inc.

Ticker LCTX · SEC CIK 0000876343

Track this companyFree. Adds Lineage Cell Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.

Clinical trials53 recruiting or active

Pipeline programs4From trials and the company's site

Disclosed deals0None found yet

Cash runwayNot availableNo recent cash burn filed

Pipeline4

AST-OPC1Phase 2 · Cervical Spinal Cord InjuryClinicalTrials.gov · fetched Nov 12, 2026
GRNOPC1Phase 1 · Spinal Cord InjuryClinicalTrials.gov · fetched Nov 12, 2026
OPC1Phase 1 · Spinal Cord Injury CervicalClinicalTrials.gov · fetched Nov 12, 2026
Magnetic Resonance Imaging (MRI)Spinal Cord InjuriesClinicalTrials.gov · fetched Nov 12, 2026

A Study to Evaluate the Safety of a Delivery Device for Administering LCTOPC1 in Participants With Spinal Cord InjuryPHASE1 · RECRUITING · started Jun 30, 2025ClinicalTrials.gov NCT06841770 · fetched Nov 12, 2026
LTFU Study of Subjects With Cervical SCI Who Received AST-OPC1ACTIVE_NOT_RECRUITING · started Jun 13, 2018ClinicalTrials.gov NCT05975424 · fetched Nov 12, 2026
Dose Escalation Study of AST-OPC1 in Spinal Cord InjuryPHASE1_PHASE2 · COMPLETED · started Mar 1, 2015ClinicalTrials.gov NCT02302157 · fetched Nov 12, 2026
LTFU Study of Subjects Who Received GRNOPC1ACTIVE_NOT_RECRUITING · started Oct 6, 2011ClinicalTrials.gov NCT05919563 · fetched Nov 12, 2026
Safety Study of GRNOPC1 in Spinal Cord InjuryPHASE1 · COMPLETED · started Oct 1, 2010ClinicalTrials.gov NCT01217008 · fetched Nov 12, 2026